Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Raymond J. Bergeron is active.

Publication


Featured researches published by Raymond J. Bergeron.


Biochemical and Biophysical Research Communications | 1984

Antineoplastic and antiherpetic activity of spermidine catecholamide iron chelators

Raymond J. Bergeron; Paul F. Gavanaugh; Steven J. Kline; Robert G. Hughes; Gary T. Elliott; Carl W. Porter

A series of iron chelating agents including the bacterial siderophores, parabactin and bis-N1,N8(2,3 dihydroxybenzoyl )spermidine, and four related compounds were synthesized and tested biologically. They were found: (a) to inhibit growth of cultured L1210 leukemia cells at IC50 values of 2-14 microM, (b) to inhibit replication of the DNA virus, herpes simplex type I, in monkey kidney cells at IC50 values of 0.4 microM ( parabactin ) to 55 microM, and (c) to be inactive against the RNA virus, vesicular stomatitis, at concentrations up to 1 mM. All effects were fully preventable by exogenous Fe (III). The activities correlated generally with the iron formation constants (10(36) to 10(48) moles/1) and more specifically with the lipophilicity of the compounds. The data suggest inhibition of DNA (but not RNA) synthesis by interference with the iron-containing enzyme, ribonucleotide reductase.


Advances in Enzyme Regulation | 1988

Enzyme regulation as an approach to interference with polyamine biosynthesis — an alternative to enzyme inhibition

Carl W. Porter; Raymond J. Bergeron

The progress reviewed here would seem to validate the regulatory approach to interference with polyamine biosynthesis as an antiproliferative strategy. To our knowledge, this is the first example, among anticancer drugs, of pharmacological intervention of a biochemical pathway based strictly on regulatory control. Several features of polyamine biology naturally favor this approach and may account for its relative success. These include (a) the nature of the regulatory mechanisms themselves, (b) the exquisite sensitivity of the pathway to regulatory control, (c) the rapid turnover of ODC and AdoMetDC, (d) the different structural specificity of ODC and AdoMetDC regulation versus growth-dependent functions, and (e) the direct dependence of growth on sustained polyamine biosynthesis. As such, the regulatory approach to interference with polyamine biosynthesis offers several advantages over the use of specific enzyme inhibitors (Table 10). Of these, perhaps, the more significant are the facts that more than one enzyme can be simultaneously and specifically suppressed and that compensatory mechanisms, which otherwise counter the effects of enzyme inhibitors (11), are not invoked. We are encouraged by the concurrence of in vitro mechanistic findings with the predictions of the hypothesis for the regulatory approach and by the in vitro and in vivo growth inhibitory effects of the analogs against murine leukemia. One disadvantage of the regulatory analogs, such as BESm, has been that, as with specific polyamine inhibitors such as DFMO, analog-induced polyamine depletion results in cytostatic growth inhibition. While this response may help to minimize host toxicities, it clearly compromises antitumor activity. An intriguing exception to this generality has recently been found among human lung carcinoma cell lines. Previously, Luk et al. (93, 94) and others (95) reported that, among a spectrum of human lung carcinoma lines, small cell carcinoma was exquisitely sensitive to the ODC inhibitor, DFMO. Not only did these cells display a cessation of growth but also an inability to survive during DFMO-induced polyamine depletion. Studies extending these findings to long term maintenance therapy in human small cell lung carcinoma implants in athymic mice revealed sustained growth inhibition of the tumor for longer than one year (96). Casero et al. (97) now find that human large cell carcinoma, which is otherwise refractory to chemotherapeutic intervention, displays a cytotoxic response in vitro to polyamine depletion induced by BES or BESm but not by DFMO.(ABSTRACT TRUNCATED AT 400 WORDS)


Bioorganic Chemistry | 1976

The molecular disposition of sodium p-nitrophenolate in the cavities of cycloheptaamylose and cyclohexaamylose in solution

Raymond J. Bergeron; Robert Rowan

Abstract The extent to which sodium p -nitrophenolate penetrates the cycloheptaamylose and cyclohexaamylose cavities has been defined by nmr studies of the complexes in aqueous solution. Measurements of changes in the 1 H nmr spectra of both the sodium p -nitrophenolate guest and the cyclohexaamylose host, along with an intermolecular nuclear Overhauser effect, reveal that this guest only partially penetrates the cyclohexaamylose cavity and does so nitro end first. With cyclohepaamylose, sodium p -nitrophenolate penetrates more deeply, but the orientation may be less specific. These findings are in accord with the notion that both London dispersion forces and removal of high energy cavity water contribute to substrate binding.


Tetrahedron Letters | 1973

Triflamides: new acylating and triflating reagents

James B. Hendrickson; Raymond J. Bergeron

Durch Behandlung mit Trifluormethansulfonsaureanhydrid (I) erhalt man aus den mit z.B. NaH hergestellten Amid-Anionen wie (II) die Acylierungsmittel (III), die bestandig sind und mit nucleophilen Reagentien (IV) zu den Acylverbindungen (V) umgesetzt werden.


Biochemical Pharmacology | 1989

Structure-function correlations of polyamine analog-induced increases in spermidine/spermine acetyltransferase activity

Paul R. Libby; Raymond J. Bergeron; Carl W. Porter

The cytosolic enzyme, spermidine/spermine acetyltransferase (SSAT), is distinguished by its role in polyamine interconversion and by its high inducibility in response to a variety of physiological and pharmacological stimuli. Among a series of fifteen polyamines and polyamine analogs, the most potent inducers of SSAT activity in cultured L1210 cells were found to be N1,N8-bis(ethyl)spermidine (BES) and N1,N12-bis(ethyl)spermine (BESm). Over a 24-hr exposure at 10 microM, enzyme activity rose 13- and 16-fold with BES and BESm, respectively, compared to 2- to 3-fold with the anticancer agent, methylglyoxal bis(guanylhydrazone). The increase in enzyme activity by BESm began rapidly and continued steadily with time so that by 48 hr it increased to about twenty times control. By inhibitor studies, the increase was found to be due to elevated protein synthesis predominantly at the level of translation and to an apparent prolongation of enzyme half-life related to enzyme stabilization. Among the analogs, the structural requirements for maximum enzyme induction were found to be critically dependent on aminopropyl moieties and on the presence, size and location of the alkyl groups. By structure-function comparisons, it was deduced that the known abilities of BES and BESm to regulate ornithine and S-adenosylmethionine decarboxylase activities or to inhibit cell growth occur independently of their effects on SSAT activity in L1210 cells.


Tetrahedron | 2003

Total synthesis and structure revision of petrobactin

Raymond J. Bergeron; Guangfei Huang; Richard E. Smith; Neelam Bharti; James S. McManis; Alison Butler

Abstract The total synthesis and the revised structural assignment of petrobactin, a siderophore isolated from the marine bacterium Marinobacter hydrocarbonoclasticus, is reported. The key step in the synthesis involved condensation of N1-(2,3-dibenzoyloxybenzoyl)-N4-benzylspermidine with 1,3-di-(p-nitrophenyl)-2-tert-butyl citrate. Proton NMR spectra of the synthesized product compared with those reported for the natural product revealed that the compound did not contain 2,3-dihydroxybenzoyl moieties as published; instead, the splitting pattern suggested 3,4-dihydroxybenzoyl fragments. The 3,4-dihydroxybenzoyl analogue was accessed via a similar route; the proton and carbon-13 NMR spectra of this compound were consistent with those reported for natural petrobactin.


Annals of the New York Academy of Sciences | 1990

A Comparative Evaluation of Iron Clearance Models

Raymond J. Bergeron; Richard R. Streiff; Jan Wiegand; J. R. Timothy Vinson; Luchetta Gr; Kimberly M. Evans; Heinrich Peter; Hans-Beat Jenny

A comparative study of the non-iron-overloaded, bile duct-cannulated rat and of the Cebus monkey as iron-clearance models is presented. The ability of desferrioxamine, desferrithiocin, and a pyridoxal isonicotinoyl hydrazone (PIH) analogue to clear the metal from these two animals is evaluated. Data suggest that although rodents represent a viable first-line animal screen, there is no strict correspondence between the effectiveness of a chelator in rodents and that in primates. Rodent data should be interpreted carefully as it relates to potential human trials. Iron-loading response, the similarity between multiple human and Cebus serum and hematological values, and the ability to easily observe changes in behavioral patterns clearly render the Cebus monkey the best preclinical screen.


Trends in Biochemical Sciences | 1986

Iron: a controlling nutrient in proliferative processes

Raymond J. Bergeron

Abstract Iron plays a critical role in many biological redox processes, and Nature has developed sophisticated systems to chelete and transport the metal. This review discusses how these systems in mammals and microorganisms may function to control proliferative processes in mammalian cells.


Tetrahedron | 1975

New “Gabriel” syntheses of amines☆

James B. Hendrickson; Raymond J. Bergeron; Daniel Sternbach

Abstract The Gabriel synthesis is generalized as monoalkylation of an ammonia or primary amine derivative with subsequent removal of the derivatizing group(s) from nitrogen. Two new derivatives for this purpose are introduced: phenacylsulfonamides and triflamides, with discussion of their generality and effectiveness.


Bioorganic Chemistry | 1976

Selective alkylation of cycloheptaamylose

Raymond J. Bergeron; Mary P. Meeley; Yoshimasa Machida

Abstract The verification of a number of assumptions made about cycloamylose structure, substrate binding and catalysis is dependent on the ability to 3- O -alkylate selectively these oligosaccharides. In the presence of barium oxide and barium hydroxide octahydrate, cycloheptaamylose reacts with 3-bromopropene in dimethylformamide and dimethyl sulfoxide to produce a high yield of tetradecakis-2,6- O -allylcycloheptaamylose, a compound which can serve as a highly versatile intermediate in the preparation of heptakis-3- O -alkylated cycloheptamyloses. Depending on the nature of the substituent to be introduced at the C-3 hydroxyl position, the intermediate allyl ether can be 3- O -alkylated and the allyl ether can be isomerized to the vinyl ether and cleaved; or, alternatively, the allyl ether can be first subjected to isomerization followed by alkylation, and then cleavage.

Collaboration


Dive into the Raymond J. Bergeron's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carl W. Porter

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Debora L. Kramer

Roswell Park Cancer Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge